share_log

Morgan Stanley Maintains Equal-Weight on Axsome Therapeutics, Lowers Price Target to $71

Morgan Stanley Maintains Equal-Weight on Axsome Therapeutics, Lowers Price Target to $71

摩根士丹利维持对Axsome Therapeutics的同等权重,将目标股价下调至71美元
Benzinga Real-time News ·  2022/09/30 08:32

Morgan Stanley analyst Vikram Purohit maintains Axsome Therapeutics (NASDAQ:AXSM) with a Equal-Weight and lowers the price target from $75 to $71.

摩根士丹利分析师维克拉姆·普罗希特维持Axsome Therapeutics(纳斯达克股票代码:AXSM)的权重相等,并将目标股价从75美元下调至71美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发